|
RNF4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.139100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.168100E-02 |
| Normal-vs-Stage2 |
4.270800E-01 |
| Normal-vs-Stage3 |
9.231800E-04 |
| Normal-vs-Stage4 |
8.614400E-04 |
| Stage1-vs-Stage2 |
7.913800E-01 |
| Stage1-vs-Stage3 |
1.084400E-02 |
| Stage1-vs-Stage4 |
2.572000E-02 |
| Stage2-vs-Stage3 |
9.123800E-02 |
| Stage2-vs-Stage4 |
7.635900E-02 |
| Stage3-vs-Stage4 |
7.843200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.144130E-02 |
| Normal-vs-AfricanAmerican |
9.715600E-01 |
| Normal-vs-Asian |
2.107000E-01 |
| Caucasian-vs-AfricanAmerican |
8.551900E-02 |
| Caucasian-vs-Asian |
4.018400E-01 |
| AfricanAmerican-vs-Asian |
3.788400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.398350E-02 |
| Normal-vs-Female |
1.542290E-02 |
| Male-vs-Female |
5.875800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.493390E-01 |
| Normal-vs-Age(41-60Yrs) |
6.640300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.515580E-03 |
| Normal-vs-Age(81-100Yrs) |
4.170200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.293400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.976000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.150600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.612400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.882200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.564000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.199860E-02 |
| Classical-VS-Follicular |
8.433600E-01 |
| Classical-VS-Other |
1.019230E-01 |
| Classical-VS-Normal |
7.297500E-02 |
| Tall-VS-Follicular |
1.594100E-02 |
| Tall-VS-Other |
7.023600E-01 |
| Tall-VS-Normal |
1.824920E-04 |
| Follicular-VS-Other |
1.952790E-01 |
| Follicular-VS-Normal |
1.959770E-01 |
| Other-VS-Normal |
8.477900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.813800E-02 |
| Normal-vs-N1 |
1.988610E-04 |
| N0-vs-N1 |
2.024000E-02 |
|
|
